T. Tsukuda et al., MODELING, SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NOVEL ANTIFUNGAL AGENTS (1), Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1819-1824
The medicinal need for safe and effective systemic antifungal agents h
as been intensified due to rapid growth of the immunocompromised patie
nt population.(1) Although azole antifungal agents, such as fluconazol
e, are most widely used today, they still have problems in efficacy (e
specially against Asp. fumigatus), resistance etc.(1) Thus, we tried t
o develop a new class of lanosterol C14-demethylase inhibitor which do
se not have a (phenethyl)triazole moiety (.Fig,I) found in all azole a
ntifungals on the market, based on the structure of restricticin 1.